The Foundation recognizes that the intersection of focused ultrasound therapy and cancer immunotherapy offers a highly promising opportunity for combination approaches to treat a variety of cancers. Through our Cancer Immunotherapy Program and in collaboration with our partners and the research community, we aim to explore and assess the full potential of focused ultrasound to turn this promise into reality.
Our Cancer Immunotherapy Program
In 2015, the Foundation established a dedicated Cancer Immunotherapy Program with a mission to explore the potential of focused ultrasound to impact the cancer immunotherapy field. Learn more >
The following videos and webinar recordings introduce the exciting fields of cancer immunotherapy and focused ultrasound.
Jill O’Donnell-Tormey, PhD, CEO of the Cancer Research Institute (CRI) and the Foundation's Chief Scientific Officer, Jessica Foley, PhD, discuss cancer immunotherapy and the ways that CRI and the Foundation are working together to advance exciting research, through a lens of the new COVID-19 environment.
Help us Fund Research
Learn more about our five-year $5 million campaign to support research on focused ultrasound’s role in immune-based treatment of cancer. Learn more >
Workshops & Symposia
Since 2015, the Foundation has organized and hosted three workshops on Cancer Immunotherapy and Focused Ultrasound, all in partnership with the Cancer Research Institute. Special sessions of our biennial symposia and other workshops have also covered cancer immunotherapy.
• Focused Ultrasound and Pancreatic Cancer Workshop Summary (PDF) - February 28-March 1, 2019
• Immunotherapy Summit (PDF) - October 14, 2016
• FUS for Glioblastoma Workshop (PDF) - November 9-10, 2015
• Alzheimer's Workshop (PDF) - September 17-18, 2015
• Immunotherapy Workshop (PDF) - February 11, 2015
Symposia Summaries• Focused Ultrasound Foundation Symposium Summary 2018 (PDF)
• Focused Ultrasound Foundation Symposium Summary 2016 (PDF)
• Focused Ultrasound Foundation Symposium Summary 2014 (PDF)
By partnering with organizations who share our passion for results and collaboration, we expand our reach in the global community, deepen stakeholder investment, and leverage our donors’ contributions to advance our mission. Partnerships include but are not limited to fundraising, in-kind contributions, awareness, strategic input, and advancing critical research.
If you would like to know more about the Foundation’s Cancer Immunotherapy initiative, please contact Chief Scientific Officer, Jessica Foley, PhD.